PUBLICATIONS. Title: GENETIC TECHNOLOGIES IN CANCER INVESTIGATION APPLICATIONS IN AGGRESIVE LYMPHOID MALIGNANCIES.
|
|
|
- Bartholomew Farmer
- 5 years ago
- Views:
Transcription
1 PUBLICATIONS ARTICLES: Title: MOLECULAR CHARACTERIZATION OF COMPLEX CHROMOSOMAL CHANGES IN DE NOVO ACUTE MYELOID LEUKEMIA: A CASE REPORT. Author(s): Nicoleta P. Berbec, Sorina M.F. Papuc, Andreea C.D.F. Tutulan- Cunita, Silvana M. Angelescu, Anca I. Lupu, Aurora A. Arghir. Source: Rev Romana Med Lab 21(1): Published: 2013 RAIS: 0. Title: ATYPICAL PRESENTATIONS OF 22q11.2 DELETION SYNDROME: EXPLAINING THE GENETIC DEFECTS AND GENOME ARCHITECTURE. Author(s): Tutulan-Cunita AC, Budisteanu M, Papuc SM, Dupont J-M, Blancho D, Lebbar A, Viot G, Lungeanu A, Arghir A. Source: Psychiat Res 197(3): ; PMID: RAIS: Times Cited: 1 (from Web of Science). Title: 3p14 INTERSTITIAL DELETION NOVEL CASE REPORT AND REVIEW. Author(s): Tutulan-Cunita AC, Papuc SM, Arghir A, Rötzer KM, Deshpande C, Lungeanu A, Budisteanu M. Source: J Child Neurol. 27(8): ; PMID: ; RAIS: Times Cited: 1 (from Web of Science). Title: ANGELMAN SYNDROME PATIENT MANAGEMENT: 5 YEARS OF CLINICAL EXPERIENCE. Author(s): Budisteanu M., Papuc S.M., Tutulan-Cunita A., Craiu D, Barca D., Iliescu C., Arghir A. Source: Int. J. Disabil. Hum. Dev. 0(0): 1 6 DOI: /ijdhd RAIS: Title: AUTISM AND THE GRAND CHALLENGES IN GLOBAL MENTAL HEALTH. Author(s): Khan NZ, Gallo LA, Arghir A, Budisteanu B, Budisteanu M, Dobrescu I, Donald K, El-Tabari S, Hoogenhout M, Kalambayi F, Kawa R, Espinoza IL, Lowenthal R, Malcolm-Smith S, Montiel-Nava C, Odeh J, de Paula CS, Rad F, Tarpan AK, Thomas KG, Wang C, Patel V, Baron-Cohen S, Elsabbagh M. Source: Autism Res. 5(3): ; PMID: ; RAIS: Times Cited: 1 (from Web of Science) Title: GENETIC TECHNOLOGIES IN CANCER INVESTIGATION APPLICATIONS IN AGGRESIVE LYMPHOID MALIGNANCIES.
2 Author(s): Berberc NM, Arghir A, Vitcu A, Angelescu S, Colita A., Ciobanu A, Papuc SM, Tutulan-Cunita AC, Lupu AR. Maedica A Journal of Clinical Medicine, 7(1): 75-79; PMID: Title: VARIANT E19A2 BCR-ABL1 FUSION TRANSCRIPT IN TYPICAL CHRONIC MYELOID LEUKEMIA Author(s): Tutulan-Cunita A.C., Chirieac (Papuc) S.M., Mocanu G., Luca C., Costache M., Lungeanu A., Arghir A. Source: Clinical Laboratory 57: ; PMID: Published: 2011 RAIS: Title: NOVEL CLINICAL FINDING IN MECP2 DUPLICATION SYNDROME: A CASE REPORT. Author(s): Budisteanu M., Chirieac (Papuc) S.M., Tutulan-Cunita A., Budisteanu B., Arghir A. Source: Eur. Child Adolesc. Psychiatry 20: ; PMID: ; Published: 2011 RAIS: Times Cited: 2 (from Web of Science). Title: COMPLEX CHROMOSOMAL ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA PRECEDED BY THROMBOCYTEMIA AND TRANSFORMED INTO PROMYELOCITIC BLASTIC PHASE A CASE REPORT. Author(s): Arghir A., Papuc S.M., Angelescu S., Berbec N., Tutulan-Cunita A., Mut-Popescu D., Lungeanu A. University Journal of Hemostasis and Thrombosis (ISSN , ISSN-L ), vol I: 25-28; Published: 2011 Title: OCULOCUTANEOUS ALBINISM ASSOCIATED WITH MULTIPLE MALFORMATIONS AND PSYCHOMOTOR RETARDATION. Author(s): M. Budisteanu, A. Arghir, S.M. Chirieac (Papuc), G. Cardos, A. Lungeanu. Source: Pediatric Dermatology 27(2): ; PMID: ; RAIS: Times Cited: 1 (from Web of Science). Title: 18q DELETION SYNDROME A CASE REPORT. Author(s): M. Budisteanu, A. Arghir, S.M. Chirieac (Papuc), A.C. Tutulan- Cunita, A. Lungeanu. Maedica - A Journal of Clinical Medicine, 5(2): ; PMID: ;. Title: GENETIC TESTING IN MYELODYSPLASTIC SYNDROMES CONTRIBUTION IN DIAGNOSIS, PROGNOSTIC AND CLINICAL MANAGEMENT. Author(s): A. Arghir, S.M. Chirieac (Papuc), N. Berbec, O. Ciocan, A.C. Tutulan-Cunita, A. Lungeanu.
3 Biologie moleculara, Tom XI, fasc. 2-3, p.15-20, 2010 (ISSN ). Title: MICROARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) BETWEEN BASIC RESEARCH AND CLINICAL DIAGNOSTIC. Author(s): A.C. Tutulan-Cunita, M. Budisteanu, S.M. Chirieac (Papuc), A. Arghir, G. Cardos, A. Lungeanu. Biologie moleculara, Tom XI, fasc. 2-3, p.27-32, (ISSN );. Title: RARE HEMATOLOGIC NEOPLASMS AN ACUTE MEGAKARYOCYTIC LEUKEMIA CASE REPORT. Author(s): S.M. Chirieac (Papuc), A. Arghir, H. Bumbea, A.M. Vladareanu, S. Radesi, A.C. Tutulan-Cunita, A. Lungeanu. Biologie moleculara, Tom XI, fasc. 2-3, p , 0 (ISSN ). Title: COHEN SYNDROME A RARE GENETIC CAUSE OF HYPOTONIA IN CHILDREN. Author(s): Budişteanu M, Bârcă D, Chirieac (Papuc) SM, Măgureanu S. Maedica A Journal of Clinical Medicine, 5(8): 56-61; PMID: ; Title: CHROMOSOME Y ISODICENTRICS IN TWO CASES WITH AMBIGUOUS GENITALIA AND FEATURES OF TURNER SYNDROME. Author(s): Lungeanu A., Arghir A., Arps S., Cardos G., Dumitriu N., Budisteanu M., Chirieac (Papuc) S., Rodewald A. Source: Balkan Journal of Medical Genetics, Nr. 11(2): Published: 2008 RAIS: 0. Title: PHENOTYPIC VARIABILITY IN ANGELMAN SYNDROME REPORT OF TWO CASES. Author(s): M. Budisteanu, A. Arghir, G. Cardos, S. M. Chirieac (Papuc), S. Magureanu, D. Blancho, J.-M. Dupont, A. Lungeanu. Maedica A Journal of Clinical Medicine, 3(4): ; Published: 2008 Title: CYTOGENETIC ABNORMALITIES AND REPRODUCTIVE FAILURES. Author(s): A. Lungeanu, A. Stana, A. Arghir, M. Bari, M. Budisteanu. Maedica A Journal of Clinical Medicine, 2(2): 11-20;
4 MEETING ABSTRACTS (Source Web of Science) Title: (MICRO) DELETION/(MICRO)DUPLICATION SYNDROMES IN CHILDREN WITH MENTAL RETARDATION Author(s): Budisteanu, B.; Budisteanu, M.; Papuc, S. M.; et al. Source: EUROPEAN PSYCHIATRY Volume: 27 Supplement: 1 Meeting Abstract: P-764 Title: MANAGEMENT OF CHILDREN WITH ANGELMAN SYNDROME Author(s): Budisteanu, M.; Papuc, S.; Tutulan-Cunita, A.; et al. Source: EUROPEAN PSYCHIATRY Volume: 27 Supplement: 1 Meeting Abstract: P-765 Title: XQ28 DUPLICATION IN A BOY WITH MENTAL RETARDATION, HYPERKINESIA AND DYSMORPHIC FEATURES - A CASE REPORT Author(s): Budisteanu, B.; Arghir, A.; Tutulan-Cunita, A.; et al. Source: EUROPEAN PSYCHIATRY Volume: 26 Supplement: 1 Meeting Abstract: P Published: 2011 Title: INVESTIGATION OF MENTAL RETARDATION ETIOLOGY IN ROMANIAN CHILDREN USING CLINICAL, CYTOGENETIC AND ARRAY-CGH DIAGNOSTIC TECHNIQUES Author(s): Budisteanu, M.; Arghir, A.; Chirieac, S. M.; et al. Source: EUROPEAN PSYCHIATRY Volume: 26 Supplement: 1 Meeting Abstract: P Published: 2011 Title: THERAPEUTIC APPROACHES IN CHILDREN WITH ANGELMAN SYNDROME Author(s): Budisteanu, M.; Arghir, A.; Chirieac, S-M; et al. Conference: 9th European Congress on Epileptology Location: Rhodes, GREECE Date: JUN 27-JUL 01, 2010 Source: EPILEPSIA Volume: 51 Special Issue: SI Supplement: 4 Pages: Published: JUN 2010 Title: EPILEPSY IN CHILDREN WITH ANGELMAN SYNDROME Author(s): Budisteanu, M.; Arghir, A.; Chirieac, S.; et al. Conference: 28th International Epilespy Congress Location: Budapest, HUNGARY Date: 2009 Source: EPILEPSIA Volume: 50 Pages: Published: OCT 2009 Title: IDENTIFICATION OF A SMALL SUPERNUMERARY MARKER CHROMOSOME IN A CASE OF DOWN SYNDROME Author(s): Lungeanu, A.; Arghir, A.; Budisteanu, M.; et al. Conference: 7th European Cytogenetics Conference Location: Stockholm, SWEDEN Date: JUL 04-07, 2009
5 Sponsor(s): European Cytogeneticists Assoc Source: CHROMOSOME RESEARCH Volume: 17 Supplement: 1 Pages: Published: JUN 2009 Title: RARE CHROMOSOMAL ABNORMALITIES ASSOCIATED WITH MENTAL RETARDATION AND MULTIPLE MALFORMATIONS Author(s): Budisteanu, M.; Arghir, A.; Chirieac, S.; et al. Conference: 7th European Cytogenetics Conference Location: Stockholm, SWEDEN Date: JUL 04-07, 2009 Sponsor(s): European Cytogeneticists Assoc Source: CHROMOSOME RESEARCH Volume: 17 Supplement: 1 Pages: Published: JUN 2009 Title: CYTOGENETIC AND MOLECULAR STUDY OF BCR/ABL NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS: PRELIMINARY DATA Author(s): Hinescu, A. Arghir; Cardos, G.; Diaconu, C.; et al. Source: CHROMOSOME RESEARCH Volume: 15 Supplement: 1 Pages: Title: A NEW CHRONIC MYELOID LEUKEMIA CASE WITH VARIANT PHILADELPHIA TRANSLOCATION Author(s): Lungeanu, A. Arghir; Chelu, G.; Cardos, G. Source: CHROMOSOME RESEARCH Volume: 15 Supplement: 1 Pages: Title: BCR/ABL FUSION AND COMPLEX CHROMOSOMAL REARRANGEMENT IN A CHRONIC MYELOID LEUKEMIA CASE - TWO STEP VARIANT TRANSLOCATION OR ADDITIONAL ANOMALY? Author(s): Arghir, G. Cardos; Mocanu, G.; Chelu, G.; et al. Source: CHROMOSOME RESEARCH Volume: 15 Supplement: 1 Pages:
Senior researcher III/ Head of Research Psychiatry Laboratory Alexandru Obregia Clinical Hospital of Psychiatry
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Magdalena Budisteanu Address(es) 1 Veronica Micle St., Bucharest, Romania Telephone(s) 0040213349068 Mobile: 0040722929091 Fax(es)
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and
Sharan Goobie, MD, MSc, FRCPC
Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations
What s the Human Genome Project Got to Do with Developmental Disabilities?
What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the
Role of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014
Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics
SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,
CHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:
MicroRNA-29a Reveals Oncogenic Role on Myeloid Malignancies by Regulating DNMT3A
MicroRNA-29a Reveals Oncogenic Role on Myeloid Malignancies by Regulating DNMT3A Heba Alkhatabi, PhD Assistant Professor Department of Medical Laboratory Collage of Applied Medical science King Abdul Aziz
Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction
Genetic Findings in Children with Unexplained Developmental Delay Dr Dipti Deshmukh Neurodevelopmental Consultant, St. George's Hospital, London Mayu Uemura 4th year MBBS4, St George s University of London
SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,
Test Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091534 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 105316AM 2/9/2017 104147AM Ref By Final LEUKEMIA GENETIC ROFILE ANY SIX MARKERS, CR QUALITATIVE AML ETO
22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)
22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases
Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC
Molecular Markers Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Testing methods Rationale for molecular testing
June 11, Ella Noel, D.O., FACOI 1717 West Broadway Madison, WI
June 11, 2018 Ella Noel, D.O., FACOI 1717 West Broadway Madison, WI 53713 policycomments@wpsic.com RE: Draft Local Coverage Determination: MolDX: MDS FISH (DL37772) Dear Dr. Noel Thank you for the opportunity
Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation
Pediatr Neonatol 2008;49(6):213 217 REVIEW ARTICLE Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Jao-Shwann Liang 1,2 *, Keiko Shimojima
Phenotypic variability in Angelman syndrome report of two cases
Mædica - a Journal of Clinical Medicine CASE REPORTS Phenotypic variability in Angelman syndrome report of two cases Magdalena BUDISTEANU a,b, Aurora ARGHIR b, Georgeta CARDOS b, Sorina CHIRIEAC b, Sanda
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه
Genetic Testing for Single-Gene and Multifactorial Conditions
Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE MARCH 31, 2019 Appropriate.Safe.Affordable 2019 AIM Specialty Health 2069-0319 Table of Contents
ONE STEP MULTIPLEX RT-PCR FOR BCRlABL GENE IN MALAY PATIENTS DIAGNOSED AS LEUKAEMIA
ONE STEP MULTIPLEX RT-PCR FOR BCRlABL GENE IN MALAY PATIENTS DIAGNOSED AS LEUKAEMIA 1Rosline H, 1Majdan R, 1Wan Zaidah A, 1Rapiaah M, 1Selamah G, 2A A Baba, 3D M Donald 1Department of Haematology, 2Department
CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
Prenatal Diagnosis: Are There Microarrays in Your Future?
Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?
Hematopathology Case Study
Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An
Cytogenetic abnormalities and reproductive failures
Mædica - a Journal of Clinical Medicine ORIGIN RIGINAL PAPERS APERS: CLINICAL OR BASIC RESEARCH Cytogenetic abnormalities and reproductive failures Agripina LUNGEANU a, CSI, PhD, Adriana STANA b, Assistant
The First National Congress of the Romanian Society of Bone Marrow Transplant - Bone Marrow Transplant A Life-Saving Treatment -
The First National Congress of the Romanian Society of Bone Marrow - Bone Marrow A Life-Saving Treatment - 19 th -21 st of June, 2017, Ramada Parc Hotel, Bucharest SCIENTIFIC PROGRAMME Monday, 19.06.2017
A. ILEA 1* A. M. VLADAREANU 2 E. NICULESCU-MIZIL 3
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 9 (58) No. 1-2016 THE SIMULTANEOUS OCCURRENCE OF THE BCR-ABL TRANSLOCATION AND THE Jak2V617F MUTATION. DETECTION AND DYNAMICS
Genetic Testing for Single-Gene and Multifactorial Conditions
Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents
Test Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091533 Age 28 Years Gender Male 1/9/2017 120000AM 1/9/2017 105415AM 4/9/2017 23858M Ref By Final LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE, ANY 6 MARKERS t (1;19) (q23
Test Name Results Units Bio. Ref. Interval. Positive
Lab No 135091548 Age 35 Years Gender Female 1/9/2017 120000AM 1/9/2017 103420AM 4/9/2017 23753M Ref By Dr UNKNWON Final Test Results Units Bio Ref Interval LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE 3 t (1;19)
Case 1B. 46,XY,-14,+t(14;21)
Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short
Clinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont
Clinical Cytogenomics Laboratory Leading diagnostics for better medicine Beaumont Laboratory Beaumont Laboratory s Clinical Cytogenomics Lab Genome decoding is essential Knowledge of variations in genome
Molecular Methods in the Diagnosis and Prognostication of Melanoma: Pros & Cons
Molecular Methods in the Diagnosis and Prognostication of Melanoma: Pros & Cons Ben J. Friedman, MD Senior Staff Physician Department of Dermatology Department of Pathology and Laboratory Medicine Henry
New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads
New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor
Myelodysplastic Syndrome Case 158
Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was
Addressing the challenges of genomic characterization of hematologic malignancies using microarrays
Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Sarah South, PhD, FACMG Medical Director, ARUP Laboratories Department of Pediatrics and Pathology University
Determination of Genomic Imbalances by Genome-wide Screening Approaches
Overview Determination of Genomic Imbalances by Genome-wide Screening Approaches Károly Szuhai Introduction/Methodologies Applications/Results Conclusion Approaches Introduction/Methodologies Chromosome
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
review Genetics IN Medicine 13
January 2008 Vol. 10 No. 1 review Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives Sandra Darilek, MS, Patricia Ward, MS, Amber Pursley, MS,
Cytogenetics Technologies, Companies & Markets
Cytogenetics Technologies, Companies & Markets By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland November 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R A P H Y Professor
Hematology Unit Lab 2 Review Material
Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th
Updating penetrance estimates for syndromes with variable phenotypic manifestation Adele Corrigan June 27th Background Array CGH has led to increased identification of copy number variants (CNVs) Our understanding
Hematopathology Case Study
www.medfusionservices.com Hematopathology Case Study CV3515-14 JUNE Clinical Presentation: Clinical Information: A 42 year old male with history of chronic myelogenous leukemia (CML) presents with an elevated
Peking University People's Hospital, Peking University Institute of Hematology
Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100
SNP Microarray. Prenatal
SNP Microarray Prenatal SNP Microarray Reveal SNP Microarray is a test that analyzes chromosomes for changes that can explain certain kinds of birth defects. This brochure is designed to answer some of
Treatment Manual Of Acute Leukemia By Ward D Merkeley
Treatment Manual Of Acute Leukemia By Ward D Merkeley If searched for the ebook Treatment manual of acute leukemia by Ward D Merkeley in pdf format, then you have come on to the correct website. We presented
MPL W515L K mutation
MPL W515L K mutation BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
When to suspect Prader Willi Syndrome and how to diagnose it?
When to suspect Prader Willi Syndrome and how to diagnose it? Dr Chirita-Emandi Adela Dr Dobrescu Andreea Victor Babes University of Medicine and Pahrmacy Timisoara Emergency Hospital for Children Louis
Clinical evaluation of microarray data
Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray
SUPPLEMENTARY INFORMATION
Supplementary Information S1 Frequency of DNMT3A mutations in hematologic disorders and their associated clinical phenotypes. Disease Patient population Frequency (%) Associated Clinical Characteristics
ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
Case Report Severe Psychomotor Delay in a Severe Presentation of Cat-Eye Syndrome
Case Reports in Genetics Volume 2015, Article ID 943905, 4 pages http://dx.doi.org/10.1155/2015/943905 Case Report Severe Psychomotor Delay in a Severe Presentation of Cat-Eye Syndrome Guillaume Jedraszak,
JAK2 V617F analysis. Indication: monitoring of therapy
JAK2 V617F analysis BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
FEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: 2.04.122 Chromosomal Microarray Analysis for the Evaluation of Pregnancy Loss 2.04.59 Genetic Testing for Developmental Delay/Intellectual
( Compauson of the JJsefulness_and_CoSts of R.r.AhI Analysis yprcnc. Chromosome Analyse
GARY MOCKLI ( Compauson of the JJsefulness_and_CoSts of R.r.AhI Analysis yprcnc Chromosome Analyse S^cv"to^n^termine Wh6ther bcr'abi anai>'sis can be utilized to ^valua* 7hSf I?f.Cemin hematopoietic malignancies
Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1+)
Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1+) Version: CMLBiomarkers 1.0.0.2 Protocol Posting Date: June 2017 This biomarker template is
Case Workshop of Society for Hematopathology and European Association for Haematopathology
Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history
Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy
Genomic complexity and arrays in CLL Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Clinical relevance of genomic complexity (GC) in CLL GC has been identified as a critical negative
Objectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013
Molecular Markers in Hematologic Malignancy: Ways to locate the needle in the haystack. Objectives Review the types of testing for hematologic malignancies Understand rationale for molecular testing Marcie
Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD
Opportunities for Optimal Testing in the Myeloproliferative Neoplasms Curtis A. Hanson, MD 2013 MFMER slide-1 DISCLOSURES: Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-2
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS
Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD
Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance
Supplementary Figure 1. Spitzoid Melanoma with PPFIBP1-MET fusion. (a) Histopathology (4x) shows a domed papule with melanocytes extending into the
Supplementary Figure 1. Spitzoid Melanoma with PPFIBP1-MET fusion. (a) Histopathology (4x) shows a domed papule with melanocytes extending into the deep dermis. (b) The melanocytes demonstrate abundant
Index. Child Adolesc Psychiatric Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Child Adolesc Psychiatric Clin N Am 16 (2007) 745 749 Index Note: Page numbers of article titles are in boldface type. A Adolescent(s), velocardiofacial syndrome in, psychiatric disorders associated with,
DETERMINANT VALUE OF THE CYTOGENETIC AND MOLECULAR IMATINIB THERAPEUTIC RESPONSE IN CHRONIC MYELOID LEUKEMIA
Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, TOM XIV, 2013 DETERMINANT VALUE OF THE CYTOGENETIC AND MOLECULAR IMATINIB THERAPEUTIC RESPONSE IN CHRONIC
A 420 Kb Deletion within the Minimum Critical Region of the 15q24 Microdeletion Syndrome in a Female Infant
North American Journal of Medicine and Science Oct 2014 Vol 7 No.4 171 Case Report A 420 Kb Deletion within the Minimum Critical Region of the 15q24 Microdeletion Syndrome in a Female Infant Deling Li,
Deletion of Short Arm of Chromosome No. 4 (4p-)-Wolf Hirschorn Syndrome Seizure Disorder, Control on Levetiracetam
Deletion of Short Arm of Chromosome No. 4 (4p-)-Wolf Hirschorn Syndrome Seizure Disorder, Control on Levetiracetam Zainab H. Al Alawi King Faisal University, Alahsa Abstract: Wolf-Hirschhorn syndrome (WHS)
Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation
Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation American Society for Clinical Pathology 2014 Annual Meeting Presented by: Matthew T. Howard, MD Assistant
[COMPREHENSIVE GENETIC ASSAY PANEL ON
2014 SN GENELAB AND RESEARCH CENTER DR. SALIL VANIAWALA, PH.D [COMPREHENSIVE GENETIC ASSAY PANEL ON MYELOPROLIFERATIVE NEOPLASMS] SN Genelab presents one of the most comprehensive genetic assay panel for
YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow
74y old Female with chronic elevation of Platelet count August 18, 2005 Faizi Ali, MD Hematopathology Fellow Clinical History Patient is a 74y old otherwise healthy Caucasian female with no major complaint
Case Report. Introduction. Mastocytosis associated with CML Hematopathology - March K. David Li 1,*, Xinjie Xu 1, and Anna P.
Mastocytosis associated with CML Hematopathology - March 2016 Case Report Systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) involving chronic myelogenous
PROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MICROARRAY TESTING FOR DEVELOPMENTAL DELAY, AUTISM SPECTRUM DISORDER AND INTELLECTUAL DISABILITY The purpose of this policy is to
CURRICULUM VITAE. Post Address: West China Second University Hospital, Section 3, 20S, Renmin Road, Chengdu, Sichuan , China
General Information: Name: Ling Gu Gender: Female Citizenship: P. R. China CURRICULUM VITAE Post Address: West China Second University Hospital, Section 3, 20S, Renmin Road, Phone Number: 86-13568818956(mobile),
Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data
Instructions for Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data (Form 2114) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Myelodysplasia/Myeloproliferative
Cost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic
Cost-Effective Strategies in the Workup of Hematologic Neoplasm Karl S. Theil, Claudiu V. Cotta Cleveland Clinic In the past 12 months, we have not had a significant financial interest or other relationship
Genetic Testing 101: Interpreting the Chromosomes
Genetic Testing 101: Interpreting the Chromosomes Kristin Lindstrom, MD Division of Genetics and Metabolism Phoenix Children s Hospital AzAAP Pediatrics in the Red Rocks I have no disclosures for this
Case 1. Sa A.Wang, MD UT MD Anderson Cancer Center Houston, TX
Case 1 Sa A.Wang, MD UT MD Anderson Cancer Center Houston, TX Disclosure of Relevant Financial Relationships The USCAP requires that anyone in a position to influence or control the content of all CME
Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University
Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic
Clinical Policy Title: Genetic testing for primary autosomal recessive microcephaly
Clinical Policy Title: Genetic testing for primary autosomal recessive microcephaly Clinical Policy Number: (391) 02.01.03 Effective Date: June 1, 2013 Initial Review Date: April 22, 2013 Most Recent Review
Classification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. (NILOdeepR)
We are updating the design of this site. Learn more. Try the new test version at https://clinicaltrials.gov/beta/ Show less Find Studies About Studies Submit Studies Resources About Site Trial record 1
Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D.
Diagnostic Approach for Eosinophilia and Mastocytosis Curtis A. Hanson, M.D. 2014 MFMER slide-1 DISCLOSURES: Relevant Financial Relationship(s) None Off Label Usage None 2014 MFMER slide-2 Molecular Classification
A novel isothermal amplification approach for rapid identification of BCR-ABL fusion genes at onset:
A novel isothermal amplification approach for rapid identification of BCR-ABL fusion genes at onset: Josh Glason: Sales Manager, DiaSorin Australia Pty Ltd September 6, 2014 This product is not currently
Application of Whole Genome Microarrays in Cancer: You should be doing this test!!
Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Daynna Wolff, Ph.D. Director, Cytogenetics and Genomics Disclosures Clinical Laboratory Director and Employee, Medical
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.
Product Description SALSA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Version F2. Compared to version F1, two reference probes have been replaced and the 118 nt Y fragment has been
2 nd step do Bone Marrow Study If possible both the aspiration and
Blood Malignancies-I Prof. Herman Hariman,SpPK a (KH). Ph.D.(U.K) Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. Clinpath, FK-USU First do the Full Blood Count Hb, WBCS, Platelets Morphology!! Such as blasts,
Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms
Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms Version: MPNBiomarkers 1.0.0.2 Protocol Posting Date: June 2017 This biomarker template is NOT required for accreditation
WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities
WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities Robert W. McKenna, M.D. 1/2009 WHO Classification of Myeloid Neoplasms (4th Edition)--2008 Incorporates new information that
SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017
LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer
Title. CitationAnnals of Hematology, 82(9): Issue Date Doc URL. Rights. Type. File Information. major BCR/ABL
Title A case of myelodysplastic syndrome developed blastic major BCR/ABL Author(s)Onozawa, Masahiro; Fukuhara, Takashi; Takahata, Muts CitationAnnals of Hematology, 82(9): 593-595 Issue Date 2003-09 Doc
Section: Genetic Testing Last Reviewed Date: April Policy No: 58 Effective Date: July 1, 2014
Medical Policy Manual Topic: Genetic Testing, including Chromosomal Microarray Analysis (CMA) and Next Generation Sequencing Panels, for the Genetic Evaluation of Patients with Developmental Delay/Intellectual
Prior Authorization Review Panel MCO Policy Submission
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.